Farmacologic prevention with Varenicline in heavy smokers undergoing early detection lung cancer screening - ND
- Conditions
- Heavy smokers with higher risk in developing lung cancer and smoke related diseasesMedDRA version: 9.1Level: SOCClassification code 10038738MedDRA version: 9.1Level: HLGTClassification code 10038716MedDRA version: 9.1Level: HLGTClassification code 10029107MedDRA version: 9.1Level: HLTClassification code 10006334
- Registration Number
- EUCTR2009-014301-14-IT
- Lead Sponsor
- ISTITUTO NAZIONALE PER LA CURA TUMORI
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Authorised-recruitment may be ongoing or finished
- Sex
- All
- Target Recruitment
- 600
Inclusion Criteria
Healthy Smokers Age range 50-75
Are the trial subjects under 18? no
Number of subjects for this age range:
F.1.2 Adults (18-64 years) yes
F.1.2.1 Number of subjects for this age range
F.1.3 Elderly (>=65 years) yes
F.1.3.1 Number of subjects for this age range
Exclusion Criteria
Kidney, cardiovascular and neurological diseases. Depression, psychosis, eating disorder Alcohol abuse and antidepressant therapy
Study & Design
- Study Type
- Interventional clinical trial of medicinal product
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method